Virtu Financial’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76K Buy
+31,063
New +$71K ﹤0.01% 1154
2024
Q1
– Sell
-14,018
Closed -$47K – 1725
2023
Q4
$47K Buy
+14,018
New +$25.5K ﹤0.01% 1182
2023
Q1
– Sell
-15,038
Closed -$77K – 1778
2022
Q4
$77K Buy
+15,038
New +$142K 0.01% 1011

Other funds holding IPSC

Virtu Financial's IPSC Position: Q2 2026 in Review

Virtu Financial opened a new position in Century Therapeutics (IPSC) in Q2 2026: 31,063 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #1154 among its holdings. This is a return to the name: Virtu Financial previously reported a position in IPSC as recently as Q4 2023.

Virtu Financial first reported a position in IPSC in Q4 2022 and has held it in 3 quarters since. The position peaked at $77K in Q4 2022. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Virtu Financial held 31,063 shares of Century Therapeutics worth $76K as of Q2 2026.
  • Century Therapeutics was a new Virtu Financial position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1154 holding.
  • Virtu Financial first reported a position in Century Therapeutics in Q4 2022 and has held it in 3 quarters since.
  • Virtu Financial's Century Therapeutics position peaked at $77K in Q4 2022.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.